The Effect of Topical Mitomycin C after Excisional Biopsy in Conjunctival-corneal Intraepithelial Neoplasia: Two cases.
- Author:
Jung Han KIM
1
;
Hyun Sung KANG
;
In Chul KIM
Author Information
1. Department of ophthalmology, Presbyterian Medical Center. pmcoph@hitel.net
- Publication Type:Case Report
- Keywords:
Conjunctival-corneal intraepithelial neoplasia(CCIN);
Incomplete Excision;
Topical mitomycin C
- MeSH:
Biopsy*;
Drug Therapy;
Follow-Up Studies;
Humans;
Mitomycin*;
Recurrence
- From:Journal of the Korean Ophthalmological Society
2001;42(7):1102-1110
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To investigate the effect of topical Mitomycin C(MMC) as a medical adjunct to incompletely excised conjunctival-corneal intraepithelial neoplasia(CCIN) for removal of remaining neoplastic cells and prevention of recurrence. METHODS: The authors applied postoperative topical 0.02% MMC adjunctively on 2 eyes of 2 patients with incompletely excised and histopathologically confirmed conjunctival-corneal intraepithelial neoplasia(CCIN) for 2weeks and if the lesion is not regressed, topical MMC treatment with the same regimen was added. RESULTS: Remaining lesions were completely regressed and no recurrence has been found with follow up to 25 months and 26 months in each case. CONCLUSIONS: Topical MMC chemotherapy would be an effective treatment modality on incompletely excised conjunctival-corneal intraepithelial neoplasia(CCIN) for removal of remaining neoplatic cells and prevention of recurrence.
